Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Angelantonio ED, Franco OH, Halvorsen S, Richard Hobbs FD, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S et al. (2022)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Rev Esp Cardiol (Engl Ed), 75 (5), 429
DOI 10.1016/j.rec.2022.04.003, PubMed 35525570

Atar D, Langset G, Tonstad S (2022)
Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advances
Kardiol Pol (in press)
DOI 10.33963/KP.a2022.0117, PubMed 35521719

Komiyama M, Agewall S, Hasegawa K (2022)
Future of Antithrombotic Therapy for Heart Failure with Coronary Artery Disease
Eur Heart J Cardiovasc Pharmacother (in press)
DOI 10.1093/ehjcvp/pvac030, PubMed 35521703